Crescent Biopharma (CBIO) Times Interest Earned (2024 - 2025)

Crescent Biopharma (CBIO) reported Times Interest Earned of -$19.6 for Q2 2025, down 53.22% quarter-over-quarter from -$12.79 in Q1 2025.

Crescent Biopharma (CBIO) Times Interest Earned (2024 - 2025) Analysis & Trends

Crescent Biopharma (CBIO) has 2 years of Times Interest Earned data on file, last reported at -$19.6 in Q2 2025.

Times Interest Earned for Q2 2025 came in at -$19.6, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$152.04 (down 572.47% YoY), and the FY2025 annual result was -$69.85, changed N/A from the prior year.
Times Interest Earned declined to -$19.6 in Q2 2025 per CBIO's latest filing, from -$12.79 in the prior quarter.
Over five years, Times Interest Earned peaked at -$12.79 in Q1 2025 and troughed at -$20.18 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Crescent Biopharma	486.92 Mn	297.76 Mn	-	-

Download Data